Today: 1 March 2026
Subscribe

Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

Paladin Energy share price jumps after Canada clears key step for Patterson Lake South uranium project

Paladin Energy share price jumps after Canada clears key step for Patterson Lake South uranium project

Paladin Energy shares rose 3.3% to A$13.67 after securing Saskatchewan ministerial approval for the Environmental Impact Statement at its Patterson Lake South uranium project in Canada. The decision clears a key provincial hurdle, with federal licensing steps still ahead. Other uranium stocks also gained as spot prices held near $89 a pound. Paladin resumed trading after a brief halt pending the announcement.
20 February 2026
··
Telix (ASX:TLX) share price jumps 14% on 2026 revenue outlook — what moved the stock

Telix (ASX:TLX) share price jumps 14% on 2026 revenue outlook — what moved the stock

Telix Pharmaceuticals shares closed up 14.2% at A$10.43 in Sydney after reporting 2025 revenue rose 56% to US$803.8 million and forecasting 2026 revenue of US$950 million to US$970 million. The company filed for European approval of its TLX101-Px brain cancer imaging agent earlier in the week. Telix ended 2025 with US$141.9 million in cash and posted a US$5.3 million pre-tax loss.
20 February 2026
··
Whitehaven Coal share price falls again as buyback starts after half-year loss

Whitehaven Coal share price falls again as buyback starts after half-year loss

Whitehaven Coal shares dropped 2.7% to A$7.81 on Friday after posting a first-half underlying net loss of A$19 million and announcing a small buyback. Revenue for the half fell to A$2.5 billion as coal prices softened. Net debt stood at A$710 million, with a US$500 million deferred acquisition payment due in April. The company declared a 4-cent interim dividend, payable March 13.
20 February 2026
··
Evolution Mining share price edges up despite chair’s 3.25 million-share sell-down; gold and dividend date in focus

Evolution Mining share price edges up despite chair’s 3.25 million-share sell-down; gold and dividend date in focus

Evolution Mining shares closed up 0.7% at A$15.05 in Sydney after chair Jacob Klein disclosed selling 3.25 million shares at an average A$15.76 each. Klein retains 7.75 million shares and 1.56 million performance rights. Gold hovered near $5,000 an ounce but was set for a weekly drop as the dollar strengthened ahead of U.S. inflation data.
20 February 2026
····
Ethereum near $1,950 as NFT “utility” pitch meets Polymarket’s $1.17 million price bet

Ethereum near $1,950 as NFT “utility” pitch meets Polymarket’s $1.17 million price bet

Ether traded at $1,955.79 on Friday, down 0.73% in 24 hours, with $18 billion in volume, CoinMarketCap reported. Polymarket users wagered $1.17 million on ether price contracts, with settlements above $1,500 and $1,900 but not $2,000. Ethereum co-founder Vitalik Buterin warned prediction markets risk becoming “low-value gambling.” Bitcoin hovered near $67,088 late Thursday, according to Dow Jones data.
20 February 2026
··
Fortescue stock price slips to A$20 — what’s next for FMG ahead of earnings and Wyloo North

Fortescue stock price slips to A$20 — what’s next for FMG ahead of earnings and Wyloo North

Fortescue Ltd shares closed down 1.3% at A$20.04 on Friday, with 6.4 million shares traded. The company’s Wyloo North iron ore mine proposal, targeting 12 million tonnes a year, faces public comment until Feb. 24. Benchmark 62% Fe iron ore futures last traded at $99.61 a tonne. Fortescue’s half-year results are due Feb. 25.
20 February 2026
···
Wesfarmers shares wobble after profit beat, as dividend date and consumer demand come into view

Wesfarmers shares wobble after profit beat, as dividend date and consumer demand come into view

Wesfarmers shares fell 0.3% to A$83.99 on Friday, extending a 5.6% drop after its results. The company reported first-half net profit of A$1.6 billion, up 9.3%, and raised its interim dividend to A$1.02 a share. Shares go ex-dividend Feb. 24, with payment due March 31. CEO Rob Scott warned of uneven consumer spending and flagged price cuts funded by productivity and AI.
20 February 2026
···
Zip Co (ASX:ZIP) share price: A$50m buyback plan lands after brutal earnings slump

Zip Co (ASX:ZIP) share price: A$50m buyback plan lands after brutal earnings slump

Zip shares closed at A$1.78 Friday, down 3.8% after a 34% drop Thursday. The company announced an up to A$50 million on-market buyback starting around March 6. Investors reacted to flat second-half earnings guidance despite upgraded margin targets and rising credit losses. Cash EBITDA for the half-year rose 86% to A$124.3 million, but results missed expectations.
20 February 2026
···
Woodside Energy stock rises as oil stays near 6‑month highs — what to watch next week

Woodside Energy stock rises as oil stays near 6‑month highs — what to watch next week

Woodside Energy shares rose 1.2% to A$27.43 on Friday as oil prices hit six-month highs amid U.S.-Iran tensions. The S&P/ASX200 slipped 0.05%, while Santos dropped 0.9% after a new gas deal with South Australia. Woodside will release its 2025 annual report and full-year update next Tuesday. Traders remain focused on oil prices and upcoming company guidance.
20 February 2026
···
Telstra share price today: TLS slips after buyback boost as dividend dates loom

Telstra share price today: TLS slips after buyback boost as dividend dates loom

Telstra shares closed at A$5.11, down 0.6% Friday, after surging to a multi-month high on Thursday’s half-year results. The company raised its on-market buyback to A$1.25 billion and narrowed FY26 EBITDAaL guidance to A$8.2–8.4 billion. Telstra declared a 10.5 cent interim dividend, with the stock going ex-dividend Feb. 25. Profit for the half rose 9.4% to A$1.124 billion.
20 February 2026
···
CSL share price slips as buyback tally grows; Lilly deal sets up next week

CSL share price slips as buyback tally grows; Lilly deal sets up next week

CSL shares fell 0.6% to A$153.27 Friday, ending a two-day rebound. The company disclosed a 69,497-share buyback for A$10.7 million and confirmed a new licensing deal with Eli Lilly for clazakizumab, including a $100 million upfront payment. Director Alison Watkins acquired 214 shares under a board plan. Investors are watching buyback pace and updates on the Lilly agreement next week.
20 February 2026
····
1 … 10 11 12 13 14 … 584
Go toTop